Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells

被引:3
|
作者
van Hugte, Eline [1 ,2 ]
Kasri, Nael Nadif [1 ,3 ]
机构
[1] Radboudumc, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands
[2] Acad Ctr Epileptol Kempenhaeghe, Heeze, Netherlands
[3] Radboudumc, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands
关键词
Autism; Bipolar disorder; Disease modeling; iPSCs; Neuropsychiatric disorders; Neuronal differentiation; Schizophrenia; Human-induced pluripotent stem cells; HUMAN BRAIN; HUMAN FIBROBLASTS; BIPOLAR DISORDER; PYRAMIDAL NEURONS; DIRECT CONVERSION; RETT-SYNDROME; HUMAN ES; SCHIZOPHRENIA; MICROGLIA; GABA;
D O I
10.1007/978-981-32-9721-0_15
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Neuropsychiatric disorders are a heterogeneous group of disorders that are challenging to model and treat, due to their underlying complex genetic architecture and clinical variability. Presently, increasingly more studies are making use of induced pluripotent stem cell (iPSC)-derived neurons, reprogrammed from patient somatic cells, to model neuropsychiatric disorders. iPSC-derived neurons offer the possibility to recapitulate relevant disease biology in the context of the individual patient genetic background. In addition to disease modeling, iPSC-derived neurons offer unprecedented opportunities in drug screening. In this chapter, the current status of iPSC disease modeling for neuropsychiatric disorders is presented. Both 2D and 3D disease modeling approaches are discussed as well as the generation of different neuronal cell types that are relevant for studying neuropsychiatric disorders. Moreover, the advantages and limitations are highlighted in addition to the future perspectives of using iPSC-derived neurons in the uncovering of robust cellular phenotypes that consecutively have the potential to lead to clinical developments.
引用
收藏
页码:297 / 312
页数:16
相关论文
共 50 条
  • [1] Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells
    Naphade, Swati
    Tshilenge, Kizito-Tshitoko
    Ellerby, Lisa M.
    NEUROTHERAPEUTICS, 2019, 16 (04) : 979 - 998
  • [2] Modeling blood diseases with human induced pluripotent stem cells
    Georgomanoli, Maria
    Papapetrou, Eirini P.
    DISEASE MODELS & MECHANISMS, 2019, 12 (06)
  • [3] Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells
    Swati Naphade
    Kizito-Tshitoko Tshilenge
    Lisa M. Ellerby
    Neurotherapeutics, 2019, 16 : 979 - 998
  • [4] Modeling aortic diseases using induced pluripotent stem cells
    Zhu, Kai
    Ma, Wenrui
    Li, Jun
    Zhang, Yu Shrike
    Zhang, Weijia
    Lai, Hao
    Wang, Chunsheng
    STEM CELLS TRANSLATIONAL MEDICINE, 2021, 10 (02) : 190 - 197
  • [5] Modeling Neuropsychiatric and Neurodegenerative Diseases with induced Pluripotent Stem Cells
    LaMarca, Elizabeth A.
    Powell, Samuel K.
    Akbarian, Schahram
    Brennand, Kristen J.
    FRONTIERS IN PEDIATRICS, 2018, 6
  • [6] Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling
    Jiang, Wenjian
    Lan, Feng
    Zhang, Hongjia
    CURRENT STEM CELL RESEARCH & THERAPY, 2016, 11 (07) : 533 - 541
  • [7] Stem Cells on the Brain: Modeling Neurodevelopmental and Neurodegenerative Diseases Using Human Induced Pluripotent Stem Cells
    Srikanth, Priya
    Young-Pearse, Tracy L.
    JOURNAL OF NEUROGENETICS, 2014, 28 (1-2) : 5 - 29
  • [8] Induced pluripotent stem cells and neurodegenerative diseases
    Chen, Chao
    Xiao, Shi-Fu
    NEUROSCIENCE BULLETIN, 2011, 27 (02) : 107 - 114
  • [9] Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases
    Payne, Natalie L.
    Sylvaini, Aude
    O'Brien, Carmel
    Herszfeld, Daniella
    Sun, Guizhi
    Bernard, Claude C. A.
    NEW BIOTECHNOLOGY, 2015, 32 (01) : 212 - 228
  • [10] Applications of Induced Pluripotent Stem Cells in the Modeling of Human Inflammatory Bowel Diseases
    Liu, Jingquan
    Shi, Bin
    Shi, Kai
    Zhang, Hongze
    CURRENT STEM CELL RESEARCH & THERAPY, 2015, 10 (03) : 228 - 235